In a study published in the Journal of Orthopaedic Research, investigators have identified urinary markers that differentiate total hip replacement
Urinary markers predict bone problems after hip replacement
Common diabetes drug found safe for most diabetics with kidney disease: Acidosis related to use of metformin seen only in those with severely decreased kidney function
Results of a large-scale study suggest that the oral diabetes drug metformin is safe for most diabetics who also have
Some veterans at higher risk of Zika complications
Zika virus (ZIKV) has affected roughly half a million people in the Western hemisphere in recent years, including US veterans.
Tuberculosis: Pharmacists develop new substance to counteract antimicrobial resistance
Antimicrobial resistance is on the rise worldwide. This is becoming a problem for infectious diseases like tuberculosis as there are
Inpatient opioid use and insufficient weaning pre-discharge may increase outpatient opioid prescriptions
According to the University of Pittsburgh School of Medicine scientists who conducted the study, theirs is the first large-scale evaluation
How low is too low? Experts debate blood pressure targets in post-SPRINT era: Two studies provide evidence for the benefits and costs of incorporating lower systolic blood pressure targets into clinical practice
Following the landmark SPRINT trial, there is a growing body of evidence for reducing systolic blood pressure targets, resulting in
how bacteria communicate in groups to avoid antibiotics
In a new study published in the Journal of Biological Chemistry (JBC), researchers from the University of Notre Dame and
Be wary of cosmetic surgeons’ online reviews: Ratings are highly polarized, some are written by non-patients
Consumers consider online reviews important for choosing physicians, but they should be wary of using those ratings to choose plastic
Weight-loss surgery improves lives and saves money, study finds
A new BJS (British Journal of Surgery) study indicates that weight-loss surgery is cost-effective over 10 years and can save
A new class of antibiotics to combat drug resistance: Newly discovered antibiotic binds to ribosome, disrupts protein synthesis
Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of